1. Increased MCL-1 synthesis promotes irradiation-induced nasopharyngeal carcinoma radioresistance via regulation of the ROS/AKT loop.
- Author
-
Liang YY, Niu FY, Xu AA, Jiang LL, Liu CS, Liang HP, Huang YF, Shao XF, Mo ZW, and Yuan YW
- Subjects
- Cell Line, Tumor, Humans, Nasopharyngeal Carcinoma genetics, Nasopharyngeal Carcinoma pathology, Nasopharyngeal Carcinoma radiotherapy, Radiation Tolerance genetics, Reactive Oxygen Species, Myeloid Cell Leukemia Sequence 1 Protein genetics, Nasopharyngeal Neoplasms genetics, Nasopharyngeal Neoplasms pathology, Nasopharyngeal Neoplasms radiotherapy, Proto-Oncogene Proteins c-akt
- Abstract
Worldwide, nasopharyngeal carcinoma (NPC) is a rare head and neck cancer; however, it is a common malignancy in southern China. Radiotherapy is the most important treatment strategy for NPC. However, although radiotherapy is a strong tool to kill cancer cells, paradoxically it also promotes aggressive phenotypes. Therefore, we mimicked the treatment process in NPC cells in vitro. Upon exposure to radiation, a subpopulation of NPC cells gradually developed resistance to radiation and displayed cancer stem-cell characteristics. Radiation-induced stemness largely depends on the accumulation of the antiapoptotic myeloid cell leukemia 1 (MCL-1) protein. Upregulated MCL-1 levels were caused by increased stability and more importantly, enhanced protein synthesis. We showed that repeated ionizing radiation resulted in persistently enhanced reactive oxygen species (ROS) production at a higher basal level, further promoting protein kinase B (AKT) signaling activation. Intracellular ROS and AKT activation form a positive feedback loop in the process of MCL-1 protein synthesis, which in turn induces stemness and radioresistance. AKT/MCL-1 axis inhibition attenuated radiation-induced resistance, providing a potential target to reverse radiation therapy-induced radioresistance., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF